Agilent Technologies, Inc. (NYSE:A – Get Free Report) has received a consensus recommendation of “Hold” from the fourteen ratings firms that are currently covering the stock, Ratings reports. One ...
This webinar presents an optimized assay workflow using the Agilent Seahorse XF Pro Analyzer to profile T cell energy metabolism, enhancing the design and manufacturing of CAR-T cell therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback